Patent Issued for Spiro And Cyclic Bis-Benzylidene Proteasome Inhibitor For The Treatment Of Cancer, Diabetes And Neurological Disorders (USPTO 10,947,199)

Source :: Obesity, Fitness & Wellness Week. April 3, 2021, 8059
Publication Year :: 2021
Abstract: 2021 APR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor [...]

Subjects :: Therapeutics Inc. -- Intellectual property
Diabetes therapy -- Intellectual property -- Reports
Nervous system diseases -- Reports
Cancer -- Care and treatment -- Reports
Physical fitness -- Reports
Health

Tools